Publish monthly list of spurious drugs, DCGI tells state bodies

The document states the draft regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of central and state drug authorities. "This guideline will be useful for effective surveillance for quality and efficacy of drugs and cosmetics by adopting uniform drug sampling methodology for drug inspectors under drug regulatory authorities of state and central," it said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news